{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T19:12:56Z","timestamp":1781118776832,"version":"3.54.1"},"reference-count":40,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"This work was supported by the Helmsley Charitable Trust which funds the T1D Exchange QI Collaborative"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To assess barriers to diabetes technology adoption in a predominantly minority adult population with type 1 diabetes and to inform a quality improvement strategy to increase use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>An anonymous survey was distributed to 284 adults with type 1 diabetes at the University of Miami clinic. The Plan-Do-Study-Act framework was used to increase adoption of connected insulin pens among adults using multiple daily insulin injections with continuous glucose monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Hemoglobin A1c levels were lower in White non-Hispanic adults compared with Black adults (7.1 \u00b1 1.0% vs. 7.8 \u00b1 1.2%; P = 0.033) but did not differ between White non-Hispanic and White Hispanic adults. Technology use was similar across groups. Hemoglobin A1c was lower among those using insulin pump therapy with continuous glucose monitoring than among those using multiple daily insulin injections with continuous glucose monitoring (7.1 \u00b1 0.9% vs. 7.6 \u00b1 1.4%; P = 0.027). Compared with pump users with continuous glucose monitoring, adults using injections with continuous glucose monitoring reported more barriers overall (28.3% vs. 22.1%; P &amp;lt; 0.001), including nervousness about relying on technology (P = 0.010), difficulty interpreting device information (P = 0.041), and limited family support among White Hispanic adults (P = 0.032). After a multicomponent intervention, use of connected insulin pens in addition to continuous glucose monitoring increased from 18% to 27%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Increasing adoption of diabetes technology among minority adults with type 1 diabetes remains necessary, even where continuous glucose monitoring use is high.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/doc25-0072","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:17:03Z","timestamp":1776867423000},"page":"350-357","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Barriers to the Adoption of Diabetes Technologies and the Implementation of Connected Insulin Pens in a Largely Minority Population With Type 1 Diabetes"],"prefix":"10.2337","volume":"1","author":[{"given":"Maria A.","family":"Yanez Bello","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Miller School of Medicine, University of Miami 1 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Pesantez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Miller School of Medicine, University of Miami 1 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddison N.","family":"Saalinger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Miller School of Medicine, University of Miami 1 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleida M.","family":"Sanz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Miller School of Medicine, University of Miami 1 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Shikh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Miller School of Medicine, University of Miami 1 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Mesa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Miller School of Medicine, University of Miami 1 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana A.","family":"Chirinos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Miller School of Medicine, University of Miami 1 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Macias","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Miller School of Medicine, University of Miami 1 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Nisenboym","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Miller School of Medicine, University of Miami 1 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9997-3301","authenticated-orcid":false,"given":"Ernesto","family":"Bernal-Mizrachi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Miller School of Medicine, University of Miami 1 , Miami, FL"},{"name":"Miami VA Health Care System 2 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-7768","authenticated-orcid":false,"given":"Francesco","family":"Vendrame","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Miller School of Medicine, University of Miami 1 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"2026061014522051800_B1","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(23)00223-4","article-title":"Type 1 diabetes","volume":"401","author":"Quattrin","year":"2023","journal-title":"Lancet"},{"key":"2026061014522051800_B2","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.4158\/EP161392.CS","article-title":"Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology","volume":"22","author":"Fonseca","year":"2016","journal-title":"Endocr Pract"},{"key":"2026061014522051800_B3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/dia.2013.0227","article-title":"The effects of lowering nighttime and breakfast glucose levels with sensor-augmented pump therapy on hemoglobin A1c levels in type 1 diabetes","volume":"16","author":"Maahs","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"2026061014522051800_B4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/dom.13933","article-title":"Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetes","volume":"22","author":"Akturk","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"2026061014522051800_B5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2337\/dc22-0525","article-title":"Efficacy of a connected insulin pen cap in people with noncontrolled type 1 diabetes: a multicenter randomized clinical trial","volume":"46","author":"Gomez-Peralta","year":"2023","journal-title":"Diabetes Care"},{"key":"2026061014522051800_B6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/dc23-2176","article-title":"Association between treatment adherence and continuous glucose monitoring outcomes in people with diabetes using smart insulin pens in a real-world setting","volume":"47","author":"Danne","year":"2024","journal-title":"Diabetes Care"},{"key":"2026061014522051800_B7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/dia.2019.0411","article-title":"Increased time in range and fewer missed bolus injections after introduction of a smart connected insulin pen","volume":"22","author":"Adolfsson","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"2026061014522051800_B8","doi-asserted-by":"crossref","first-page":"e230108","DOI":"10.1530\/EC-23-0108","article-title":"Advantages and disadvantages of connected insulin pens in diabetes management","volume":"12","author":"Lingen","year":"2023","journal-title":"Endocr Connect"},{"key":"2026061014522051800_B9","doi-asserted-by":"crossref","first-page":"112377","DOI":"10.1016\/j.diabres.2025.112377","article-title":"Beyond glycemic metrics: real-world benefits of connected insulin pens in type 1 diabetes","volume":"226","author":"Chico","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"2026061014522051800_B10","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1056\/NEJMra2215899","article-title":"Digital technology for diabetes","volume":"389","author":"Hughes","year":"2023","journal-title":"N Engl J Med"},{"key":"2026061014522051800_B11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1542\/peds.2014-1774","article-title":"Racial-ethnic disparities in management and outcomes among children with type 1 diabetes","volume":"135","author":"Willi","year":"2015","journal-title":"Pediatrics"},{"key":"2026061014522051800_B12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2337\/cd21-0028","article-title":"Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D Exchange Quality Improvement Collaborative","volume":"39","author":"Majidi","year":"2021","journal-title":"Clin Diabetes"},{"key":"2026061014522051800_B13","doi-asserted-by":"crossref","first-page":"e2960","DOI":"10.1210\/clinem\/dgaa236","article-title":"Racial-ethnic inequity in young adults with type 1 diabetes","volume":"105","author":"Agarwal","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026061014522051800_B14","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1007\/s00125-025-06494-4","article-title":"Disparities in access to and use of diabetes technologies and therapeutics: a narrative review","volume":"68","author":"Addala","year":"2025","journal-title":"Diabetologia"},{"key":"2026061014522051800_B15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1089\/dia.2023.0320","article-title":"Longitudinal trends in glycemic outcomes and technology use for over 48,000 people with type 1 diabetes (2016\u20132022) from the T1D Exchange Quality Improvement Collaborative","volume":"25","author":"Ebekozien","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2026061014522051800_B16","doi-asserted-by":"crossref","first-page":"e2526353","DOI":"10.1001\/jamanetworkopen.2025.26353","article-title":"Trends and disparities in technology use and glycemic control in type 1 diabetes","volume":"8","author":"Fang","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026061014522051800_B17","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.2337\/dc20-3063","article-title":"Inequity in racial-ethnic representation in randomized controlled trials of diabetes technologies in type 1 diabetes: critical need for new standards","volume":"44","author":"Akturk","year":"2021","journal-title":"Diabetes Care"},{"key":"2026061014522051800_B18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2337\/dc22-1055","article-title":"Racial disparities in access and use of diabetes technology among adult patients with type 1 diabetes in a U.S. academic medical center","volume":"46","author":"Kanbour","year":"2023","journal-title":"Diabetes Care"},{"key":"2026061014522051800_B19","doi-asserted-by":"crossref","first-page":"2444002","DOI":"10.1080\/29944694.2024.2444002","article-title":"Race and ethnic disparities in insulin pump and continuous glucose monitor use between 2017 and 2024: a systematic review with a focus on health equity","volume":"2","author":"Underwood","year":"2025","journal-title":"J Health Equity"},{"key":"2026061014522051800_B20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12910-017-0179-8","article-title":"Implicit bias in healthcare professionals: a systematic review","volume":"18","author":"FitzGerald","year":"2017","journal-title":"BMC Med Ethics"},{"key":"2026061014522051800_B21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/dia.2022.0042","article-title":"Implicit racial-ethnic and insurance-mediated bias to recommending diabetes technology: insights from T1D Exchange multicenter pediatric and adult diabetes provider cohort","volume":"24","author":"Odugbesan","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026061014522051800_B22","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.2337\/dc20-2753","article-title":"Barriers to technology use and endocrinology care for underserved communities with type 1 diabetes","volume":"44","author":"Walker","year":"2021","journal-title":"Diabetes Care"},{"key":"2026061014522051800_B23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MED.0000000000000840","article-title":"Addressing disparities in technology use among patients with type 1 diabetes: a review","volume":"31","author":"Kanbour","year":"2024","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2026061014522051800_B24","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1089\/dia.2021.0075","article-title":"\"I didn\u2019t really have a choice\": qualitative analysis of racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes","volume":"23","author":"Agarwal","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2026061014522051800_B25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/dia.2021.0496","article-title":"Solutions to address inequity in diabetes technology use in type 1 diabetes: results from multidisciplinary stakeholder co-creation workshops","volume":"24","author":"Agarwal","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026061014522051800_B26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2337\/dc16-1536","article-title":"Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets","volume":"40","author":"Tanenbaum","year":"2017","journal-title":"Diabetes Care"},{"key":"2026061014522051800_B27","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.2337\/dc26-S007","article-title":"7. Diabetes technology: Standards of Care in Diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2025","journal-title":"Diabetes Care"},{"key":"2026061014522051800_B28","unstructured":"USAFacts\n          . How many people live in Florida?, 2022. Accessed 11 February 2025. Available from https:\/\/usafacts.org\/data\/topics\/people-society\/population-and-demographics\/our-changing-population\/state\/florida\/county\/miami-dade-county"},{"key":"2026061014522051800_B29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2337\/cd21-0032","article-title":"T1D Exchange Quality Improvement Collaborative: a learning health system to improve outcomes for all people with type 1 diabetes","volume":"39","author":"Weinstock","year":"2021","journal-title":"Clin Diabetes"},{"key":"2026061014522051800_B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2023.10.001","article-title":"Improving outcomes for people with type 1 diabetes through collaboration: summary of Type 1 Diabetes Exchange Quality Improvement collaborative studies","volume":"53","author":"Ebekozien","year":"2024","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2026061014522051800_B31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2337\/cd23-0050","article-title":"Increasing continuous glucose monitoring use for non-Hispanic Black and Hispanic people with type 1 diabetes: results from the T1D Exchange Quality Improvement Collaborative Equity Study","volume":"42","author":"Odugbesan","year":"2024","journal-title":"Clin Diabetes"},{"key":"2026061014522051800_B32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/1753-0407.13235","article-title":"Addressing type 1 diabetes health inequities in the United States: approaches from the T1D Exchange QI Collaborative","volume":"14","author":"Ebekozien","year":"2022","journal-title":"J Diabetes"},{"key":"2026061014522051800_B33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jcjd.2019.02.003","article-title":"Beginning a diabetes quality improvement project","volume":"43","author":"Mukerji","year":"2019","journal-title":"Can J Diabetes"},{"key":"2026061014522051800_B34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jcjd.2019.03.001","article-title":"Determining root causes and designing change ideas in a quality improvement project","volume":"43","author":"Halperin","year":"2019","journal-title":"Can J Diabetes"},{"key":"2026061014522051800_B35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcjd.2019.02.007","article-title":"Implementing change ideas, interpreting data and sustaining change in a quality improvement project","volume":"43","author":"Gilmour","year":"2019","journal-title":"Can J Diabetes"},{"key":"2026061014522051800_B36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2337\/cd22-0068","article-title":"Facilitators and barriers to smart insulin pen use: a mixed-method study of multidisciplinary stakeholders from diabetes teams in the United States","volume":"41","author":"Ospelt","year":"2022","journal-title":"Clin Diabetes"},{"key":"2026061014522051800_B37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7326\/M16-2596","article-title":"Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels","volume":"167","author":"Bergenstal","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026061014522051800_B38","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/dc06-2003","article-title":"Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program","volume":"30","author":"Herman","year":"2007","journal-title":"Diabetes Care"},{"key":"2026061014522051800_B39","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S2213-8587(22)00212-1","article-title":"Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study","volume":"10","author":"Choudhary","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026061014522051800_B40","doi-asserted-by":"crossref","first-page":"e230280","DOI":"10.20945\/2359-4292-2023-0280","article-title":"Efficacy of the hybrid closed-loop insulin delivery system in children and adolescents with type 1 diabetes: a meta-analysis with trial sequential analysis","volume":"68","author":"Oliva Morgado Ferreira","year":"2024","journal-title":"Arch Endocrinol Metab"}],"container-title":["Diabetes Obesity and Cardiometabolic CARE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/docm-care\/article-pdf\/1\/3\/350\/862687\/docm250072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/docm-care\/article-pdf\/1\/3\/350\/862687\/docm250072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:52:32Z","timestamp":1781117552000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/docm-care\/article\/1\/3\/350\/164767\/Barriers-to-the-Adoption-of-Diabetes-Technologies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4,22]]},"published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/doc25-0072","relation":{},"ISSN":["3067-3518","3067-3534"],"issn-type":[{"value":"3067-3518","type":"print"},{"value":"3067-3534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]}}}